NOLVADEX TAB 10MG 10 MG
TAMOXIFEN (TAMOXIFEN CITRATE) : 10 MG · DIN 02048477 · ASTRAZENECA CANADA INC
Health Canada status: CANCELLED POST MARKET
What is NOLVADEX TAB 10MG?
NOLVADEX TAB 10MG 10 MG contains TAMOXIFEN (TAMOXIFEN CITRATE) : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02048477, held by ASTRAZENECA CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 01-Apr-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is NOLVADEX TAB 10MG used for?
NOLVADEX (tamoxifen citrate) is indicated for the adjuvant treatment of early breast cancer in women with estrogen receptor positive tumours. NOLVADEX is indicated for the treatment of women with hormone responsive locally advanced/ metastatic breast cancer.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is NOLVADEX TAB 10MG called?
The same molecule, TAMOXIFEN, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Nolvadex-D | Latin | Australia |
| Tamoxifen Sandoz | Latin | Australia, Sweden |
| GenRx Tamoxifen | Latin | Australia |
| Neophedan | Latin | South Africa |
| Tamosin | Latin | Australia |
| Tamoxifen Ebb | Latin | Sweden |
| Farshias | Latin | Saudi Arabia |
| Nolvadex- D | Latin | South Africa |
| Tamoxifen Orifarm | Latin | Sweden |
| Tamoxifen Viatris | Latin | Sweden |
| Tremofid | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02048477 |
|---|---|
| Brand name | NOLVADEX TAB 10MG |
| Generic / active ingredient | TAMOXIFEN (TAMOXIFEN CITRATE) : 10 MG |
| Manufacturer | ASTRAZENECA CANADA INC |
| Strength | 10 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | L02BA01 TAMOXIFEN |
| AHFS class | 10:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 01-Apr-2003 |
| Original market date | 1994-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02048477 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2048477 |
| Brand name | NOLVADEX TAB 10MG |
| Active ingredient / INN | TAMOXIFEN (TAMOXIFEN CITRATE) : 10 MG |
| ATC code | L02BA01 |
| ATC anatomical main group | L — Antineoplastic and immunomodulating agents |
| ATC therapeutic subgroup | L02 |
| AHFS class | 10:00.00 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | ASTRAZENECA CANADA INC |
How is it stored and handled?
Store at room temperature (15 - 30°C) protected from light.
How is it supplied?
NOLVADEX 10 mg tablets are available in blister packs of 60 tablets. NOLVADEX-D 20 mg tablets are available in blister packs of 30 tablets.
Which pack is which?
| Strength on the label | 10 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Packaging as described in the monograph | NOLVADEX 10 mg tablets are available in blister packs of 60 tablets. NOLVADEX-D 20 mg tablets are available in blister packs of 30 tablets. |
| Storage | Store at room temperature (15 - 30°C) protected from light. |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
What can be used instead?
Other Canadian products sharing ATC code L02BA01 TAMOXIFEN. 4 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-TAMOX TAB 10MG | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 00812404 |
| APO-TAMOX TAB 20MG | 20 MG | TABLET | APOTEX INC | MARKETED | DIN 00812390 |
| TEVA-TAMOXIFEN | 10 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 00851965 |
| TEVA-TAMOXIFEN | 20 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 00851973 |
| DOM-TAMOXIFEN | 10 MG | TABLET | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02237598 |
| DOM-TAMOXIFEN | 20 MG | TABLET | DOMINION PHARMACAL | CANCELLED PRE MARKET | DIN 02237599 |
| MYLAN-TAMOXIFEN | 10 MG | TABLET | MYLAN PHARMACEUTICALS ULC | CANCELLED POST MARKET | DIN 02088428 |
| MYLAN-TAMOXIFEN | 20 MG | TABLET | MYLAN PHARMACEUTICALS ULC | CANCELLED POST MARKET | DIN 02089858 |
| NOLVADEX-D TAB 20MG | 20 MG | TABLET | ASTRAZENECA CANADA INC | CANCELLED POST MARKET | DIN 02048485 |
| PMS-TAMOXIFEN | 10 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02237459 |
Who else supplies TAMOXIFEN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TAMOXIFEN appears in 93 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does TAMOXIFEN cost around the world?
TAMOXIFEN is listed on 9 national price registers Nexara tracks, across 60 pack listings published on 8 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Australia | ex-manufacturer | 5 | 14 | 08 Sep 2026 |
| United States | acquisition | 2 | 13 | 03 Sep 2026 |
| Saudi Arabia | public | 8 | 11 | 01 Sep 2026 |
| South Africa | single exit price | 7 | 9 | 01 Sep 2026 |
| Sweden | AIP (pharmacy purchase price) | 4 | 6 | 03 Sep 2026 |
| Greece | producer price (ex-factory) | 3 | 3 | 03 Sep 2026 |
| United Kingdom | hospital | 2 | 2 | 31 Aug 2026 |
| Hungary | producer price (ex-factory) | 1 | 1 | 03 Sep 2026 |
| Romania | max producer price | 1 | 1 | 03 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.